(Q46090017)

19 December 2017

title

Increased ischaemia modified albumin following coronary artery bypass grafting (English)

1 reference

19 December 2017

coronary artery bypass surgery

main subject

1 reference

based on heuristic

inferred from title

author

Demosthenes B. Panagiotakos

3

object named as

Demosthenes Panagiotakos

1 reference

19 December 2017

author name string

Eftihia Sbarouni

1

1 reference

19 December 2017

Panagiota Georgiadou

2

1 reference

19 December 2017

Petros A Alivizatos

4

1 reference

19 December 2017

Vassilis Voudris

5

1 reference

19 December 2017

publication date

1 February 2009

1 reference

19 December 2017

published in

Biomarkers

1 reference

19 December 2017

volume

14

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

38-42

1 reference

19 December 2017

Ischemia-modified albumin in acute stroke

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

The cobalt-albumin binding assay: insights into its mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA Plus analyzer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Antioxidant defence during cardiopulmonary bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Ischemia modified albumin in relation to pharmacologic stress testing in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

The ischemia-modified albumin in relation to pacemaker and defibrillator implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Capillary leak syndrome after cardiopulmonary bypass in elective, uncomplicated coronary artery bypass grafting operations: does it exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Value of ischemia-modified albumin in the diagnosis of pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500902730706

10.1080/13547500902730706

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017